Li, Chang-Sheng <br/><br/>
[Clinical Efficacy and Safety of Different Doses of Dexamethasone Combined with Bortezomib and Thalidomide for Treating Patients with Multiple Myeloma].  [electronic resource] 

 -  Zhongguo shi yan xue ye xue za zhi  Jun 2018 
 - 836-841 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1009-2137 
<br/><br/><label>Standard No.: </label>10.7534/j.issn.1009-2137.2018.03.034  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antineoplastic Combined Chemotherapy Protocols<br/>Bortezomib<br/>Dexamethasone<br/>Disease-Free Survival<br/>Humans<br/>Multiple Myeloma<br/>Thalidomide<br/>Treatment Outcome